Why we funded it
Currently, around 2,000 men in the UK are diagnosed with
recurrent (returned) prostate cancer after radiotherapy each
year. These men are usually not offered curative treatment,
because existing therapy options target the whole prostate gland
and are oftenaccompanied by severe side effects, which can
dramatically reduce quality of life.
This study aims to find a way to precisely identify the area and
extent of cancer recurrence within the prostate gland, thus
allowing the development of targeted curative treatment. This could
potentially reduce the severity of any side effects, and make the
destruction of remaining prostate cancer an acceptable treatment
In a nutshell
Looking at using new analysis methods to combine information
from different advanced imaging techniques to precisely locate the
position and extent of recurrent cancer within the prostate. This
project has the scope to identify men suitable for existing
curative treatment of recurrent cancer, and also to pave the way
for development of localised therapies.
Find out more here.